Pharmaceutical Biotechnology

"The book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results...

Повний опис

Збережено в:
Бібліографічні деталі
Інші автори: Groves, Michael J.
Формат: Книга
Мова:Англійська
Опубліковано: Boca Raton, FL CRC Press An Imprint of Taylor & Francis Group 2006
Редагування:2nd ed.
Предмети:
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

MARC

LEADER 00000nam a22000007a 4500
008 211020b ||||| |||| 00| 0 eng d
952 |0 0  |1 0  |2 ddc  |4 0  |6 615_190000000000000_PHA  |7 0  |9 12386  |a 50008178  |b 50008178  |d 2021-03-30  |e Pharma Book Syndicate Hyderabad   |g 5881.37  |l 3  |m 1  |o 615.19 PHA  |p JP001658  |r 2024-04-05 16:54:41  |s 2024-04-05  |w 2021-10-20  |y RB 
999 |c 6937  |d 6937 
020 |a 0849318734 
020 |a 9780849318733 
082 |a 615.19  |b PHA 
245 |a Pharmaceutical Biotechnology 
250 |a 2nd ed.  
260 |a Boca Raton, FL  |b CRC Press An Imprint of Taylor & Francis Group  |c 2006 
300 |a xiv, 411 p.  
520 |a "The book gives you a working knowledge of the preparation, stability, and formulation of protein and peptide drugs. The author examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. He discusses the currently disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without significant clinical effect. The book covers the market and scientific reasons behind the failure of many biotechnology products to live up to their hype. It concludes with a discussion of regulatory and compendial issues and a look at future challenges facing biotechnology." 
650 |a Pharmaceutical Biotechnology   |9 7522 
650 |a Pharmaceutical Industry  |9 7522 
700 |a Groves, Michael J.  |9 8424